BioTheryX scoops up $35m Series D
BioTheryX Inc, a biotechnology company focused on treating difficult diseases, has raised $35 million in Series D financing.
BioTheryX Inc, a biotechnology company focused on treating difficult diseases, has raised $35 million in Series D financing.
Copyright PEI Media
Not for publication, email or dissemination
